Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma.
about
Recent advances in understanding Kaposi's sarcoma-associated herpesvirusHIV & immune reconstitution inflammatory syndrome (IRIS)KSHV: pathways to tumorigenesis and persistent infectionImmune restoration after antiretroviral therapy: the pitfalls of hasty or incomplete repairs.Pathology of rituximab-induced Kaposi sarcoma flareClinical characteristics, predictors of immune reconstitution inflammatory syndrome and long-term prognosis in patients with Kaposi sarcoma.The challenge of AIDS-related malignancies in sub-Saharan Africa.Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of AmerKSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine.Incidence and predictors of immune reconstitution inflammatory syndrome in a rural area of Mozambique.Lymphoma immune reconstitution inflammatory syndrome in the center for AIDS research network of integrated clinical systems cohortAIDS-associated Kaposi's sarcoma is linked to advanced disease and high mortality in a primary care HIV programme in South AfricaHIV and cancer in Africa: mutual collaboration between HIV and cancer programs may provide timely research and public health data.Update on KSHV epidemiology, Kaposi Sarcoma pathogenesis, and treatment of Kaposi Sarcoma.Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of theViral profiling identifies multiple subtypes of Kaposi's sarcoma.Multi-analyte profiling of ten cytokines in South African HIV-infected patients with Immune Reconstitution Inflammatory Syndrome (IRIS).KSHV-associated multicentric Castleman disease: A tangle of different entities requiring multitarget treatment strategies.Incidence, clinical spectrum, risk factors and impact of HIV-associated immune reconstitution inflammatory syndrome in South Africa.Noninfectious pulmonary complications of human immunodeficiency virus infectionInsights into pathogenic events of HIV-associated Kaposi sarcoma and immune reconstitution syndrome related Kaposi sarcoma.HIV/AIDS: epidemiology, pathophysiology, and treatment of Kaposi sarcoma-associated herpesvirus disease: Kaposi sarcoma, primary effusion lymphoma, and multicentric Castleman disease.An Update on Kaposi's Sarcoma: Epidemiology, Pathogenesis and TreatmentThe Kaposi's sarcoma-associated herpesvirus (KSHV)-induced 5-lipoxygenase-leukotriene B4 cascade plays key roles in KSHV latency, monocyte recruitment, and lipogenesis.Immune reconstitution inflammatory syndrome in HIV-infected patientsPathogenesis and prevention of immune reconstitution disease during antiretroviral therapy.Use of boosted protease inhibitors reduces Kaposi sarcoma incidence among male veterans with HIV infection.Burden, characteristics, management and outcomes of HIV-infected patients with Kaposi's sarcoma in Zomba, Malawi.Immune reconstitution inflammatory syndrome (IRIS): review of common infectious manifestations and treatment options.A Prospective Study Assessing Tumour Response, Survival, and Palliative Care Outcomes in Patients with HIV-Related Kaposi's Sarcoma at Queen Elizabeth Central Hospital, Blantyre, Malawi.Treatment of Kaposi sarcoma-associated herpesvirus-associated cancers.Phase II study of bevacizumab in patients with HIV-associated Kaposi's sarcoma receiving antiretroviral therapy.Immune reconstitution inflammatory syndrome-associated Burkitt lymphoma after combination antiretroviral therapy in HIV-infected patients.Oral HIV-Associated Kaposi Sarcoma: A Clinical Study from the Ga-Rankuwa Area, South AfricaTrends in Kaposi's Sarcoma in Miami Beach from 1987 to 2007Remission from Kaposi's sarcoma on HAART is associated with suppression of HIV replication and is independent of protease inhibitor therapyAdult human sarcomas. I. Basic science.Steroids are a risk factor for Kaposi's sarcoma-immune reconstitution inflammatory syndrome and mortality in HIV infectionRisk of Kaposi sarcoma during the first months on combination antiretroviral therapyHuman immunodeficiency virus-associated lung malignancies
P2860
Q26751238-47BB222F-3B15-4E19-9CCA-569BDC5A92E4Q26852805-50C921D2-1BEC-41F1-B68A-E6ABB668FBEDQ27026000-3A6B2EA1-A76F-4A6B-9842-51491D00C589Q27687272-87B2F523-10E7-4501-858D-682CB0F31BA1Q33354623-12509ABD-E212-459B-B124-4723C7B5AA67Q33442216-1AE698E5-DB0F-43E1-86C5-E79F4A90F697Q33523293-B84C3010-BDBA-41C3-81DF-B795EF128660Q33650105-D82DED11-2C76-4EE7-8106-B70A4ADF7580Q33761091-FAB17F72-C7B1-42A2-B1CB-29B00F96280DQ33840983-B7FC5F81-3C03-4C99-B3BE-EA4896597131Q33917964-5DA8C6D7-6828-4614-9414-4715AA4512C8Q34039651-4735B68E-1465-404E-B6F3-4C301BED1210Q34049757-8563E1CA-FDBA-4D61-A6AB-F707D31FD0B7Q34168712-02FD6557-A88D-4CF6-9B27-10546AA2B7BCQ34212799-180678DF-5233-4507-93D2-71DA55C1504BQ34237734-8F0BB9BE-C74B-48DE-9FCD-7A95AC94F5B3Q34350857-E43AD74E-21DE-4A4B-A0E1-F02735069850Q34417383-7A735AF3-3966-410F-B3F2-6B597B642A21Q34477198-96D9D5E4-3C49-49C5-9A3F-43CA3FD45F4EQ34564288-3C20CFC2-5FC5-4395-B0E4-5AA014AE0B7AQ34587349-23679613-57B0-490F-ACA0-DB18D69AC1A2Q34597442-0114EACE-86C0-4DC8-A2FE-A3A6E033B9F6Q34679512-B7F880E2-2D7C-4E25-9248-B90919316AA1Q35066362-3CA2C284-EAED-45C0-86EC-C607CA8F56D7Q35100818-184E6E6E-5796-49EA-AFCB-AD71C011732BQ35656939-8B20DD50-C405-4410-8053-CE010A40F39FQ35715660-A6C1E275-1DC4-425E-AADD-877F5AC3A61BQ35719195-3B9DC903-2B93-4F44-87F3-F666F30C3B35Q35799766-51F0E5EC-417D-463B-999E-4DEA8382692BQ35846173-01429ACF-3A22-4CE5-9CEA-2ECAE3DA2774Q35895560-93B530CA-0562-43C2-866E-AF1C23EBDD5AQ36058281-A012340E-2FC0-4078-B172-81072B90D055Q36166583-C0EACC1D-782E-4204-884A-37559C2A68AEQ36248446-A28827DF-8D40-456A-A8D3-2C2EDBD0831AQ36520006-C92506F1-36C2-4DBE-8B58-D66C5688F2D8Q36614066-E775BABE-84F7-44D9-A8C0-49493615B6D7Q36691805-E64AEA35-F069-450E-84E0-055EEBA68E9AQ36692638-0B1022A2-A298-421A-9159-32E251C8BB69Q36757480-5FE725C7-0F55-46EA-80D3-5295E4931B6FQ36897143-BBE0D820-A6BC-40AC-92FB-30B68EA96224
P2860
Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma.
description
2005 nî lūn-bûn
@nan
2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma.
@ast
Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma.
@en
Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma.
@nl
type
label
Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma.
@ast
Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma.
@en
Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma.
@nl
prefLabel
Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma.
@ast
Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma.
@en
Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma.
@nl
P2093
P356
P1476
Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma.
@en
P2093
Gazzard BG
Mandalia S
Newsom-Davis T
Stebbing J
Thirlwell C
P304
P356
10.1200/JCO.2005.14.597
P407
P577
2005-08-01T00:00:00Z